Simplex Trading’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$702K Buy
193,034
+54,564
+39% +$198K ﹤0.01% 521
2025
Q1
$265K Buy
138,470
+9,488
+7% +$18.2K ﹤0.01% 749
2024
Q4
$245K Buy
+128,982
New +$245K ﹤0.01% 878
2024
Q3
Hold
0
2202
2024
Q2
Hold
0
2325
2024
Q1
Hold
0
2285
2023
Q4
Hold
0
2319
2023
Q3
Hold
0
2184
2023
Q2
Hold
0
2293
2023
Q1
Hold
0
2235
2022
Q4
Hold
0
2429
2022
Q3
Hold
0
2620
2022
Q2
Sell
-86,989
Closed -$62K 2539
2022
Q1
$62K Buy
86,989
+31,954
+58% +$22.8K ﹤0.01% 1616
2021
Q4
$124K Buy
+55,035
New +$124K ﹤0.01% 1439
2021
Q3
Hold
0
2753
2021
Q2
Sell
-48,118
Closed -$162K 2794
2021
Q1
$162K Sell
48,118
-52,704
-52% -$177K ﹤0.01% 1201
2020
Q4
$282K Buy
100,822
+3,373
+3% +$9.43K ﹤0.01% 884
2020
Q3
$244K Buy
97,449
+52,801
+118% +$132K ﹤0.01% 772
2020
Q2
$606K Sell
44,648
-71,938
-62% -$976K ﹤0.01% 407
2020
Q1
$883K Sell
116,586
-8,094
-6% -$61.3K ﹤0.01% 329
2019
Q4
$787K Buy
124,680
+106,689
+593% +$673K ﹤0.01% 334
2019
Q3
$70K Sell
17,991
-31,856
-64% -$124K ﹤0.01% 987
2019
Q2
$241K Buy
49,847
+13,357
+37% +$64.6K ﹤0.01% 618
2019
Q1
$298K Buy
+36,490
New +$298K ﹤0.01% 552
2018
Q4
Sell
-33,863
Closed -$299K 1855
2018
Q3
$299K Sell
33,863
-14,655
-30% -$129K ﹤0.01% 630
2018
Q2
$484K Buy
48,518
+46,743
+2,633% +$466K ﹤0.01% 470
2018
Q1
$16K Sell
1,775
-346
-16% -$3.12K ﹤0.01% 1460
2017
Q4
$31K Sell
2,121
-320
-13% -$4.68K ﹤0.01% 1333
2017
Q3
$48K Buy
2,441
+1,841
+307% +$36.2K ﹤0.01% 1073
2017
Q2
$8K Sell
600
-3,354
-85% -$44.7K ﹤0.01% 1530
2017
Q1
$36K Sell
3,954
-23,178
-85% -$211K ﹤0.01% 1158
2016
Q4
$282K Buy
27,132
+4,560
+20% +$47.4K 0.02% 455
2016
Q3
$204K Buy
22,572
+5,567
+33% +$50.3K 0.01% 534
2016
Q2
$127K Buy
17,005
+6,908
+68% +$51.6K 0.01% 630
2016
Q1
$90K Buy
10,097
+7,950
+370% +$70.9K 0.01% 667
2015
Q4
$27K Sell
2,147
-31,001
-94% -$390K ﹤0.01% 1089
2015
Q3
$320K Buy
+33,148
New +$320K 0.02% 335
2015
Q2
Hold
0
1767
2015
Q1
Hold
0
1671